Cardiopulmonary drug developer Tenax Therapeutics (TENX) added nearly 13% in the premarket trading on Tuesday after Adar1 Capital Management, one of its key shareholders, bought more than $1.8M worth of company shares. – According to a regulatory filing on Monday, the Austin,…
Rises Tenax on over $1.8M Insider Buying
Cardiopulmonary drug developer Tenax Therapeutics (TENX) added nearly 13% in the premarket trading on Tuesday after Adar1 Capital Management, one of its key shareholders, bought more than $1.8M worth of company shares. - According to a regulatory filing on Monday, the Austin,...<